Hydroxychloroquine as pre-exposure prophylaxis against COVID-19 in health-care workers: A single-center experience
et al., J. Marine Medical Society, doi:10.4103/jmms.jmms_115_20
, Hydroxychloroquine as pre-exposure prophylaxis against COVID-19 in health-care workers: A single-center.., J. Marine Medical Society, doi:10.4103/jmms.jmms_115_20
90% reduction in cases with HCQ pre-exposure prophylaxis. Retrospective 604 healthcare workers.
|
risk of case, 89.5% lower, RR 0.10, p < 0.001, treatment 10 of 491 (2.0%), control 22 of 113 (19.5%), NNT 5.7.
|
|
risk of case, 88.5% lower, RR 0.12, p < 0.001, treatment 5 of 491 (1.0%), control 10 of 113 (8.8%), NNT 13, symptomatic.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Mathai et al., 6 Nov 2020, retrospective, India, peer-reviewed, 3 authors.
Loading..
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.